Concepts (109)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Elasticity Imaging Techniques | 6 | 2018 | 152 | 0.610 |
Why?
|
| Liver Cirrhosis | 8 | 2018 | 901 | 0.520 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2010 | 45 | 0.310 |
Why?
|
| Metformin | 1 | 2010 | 168 | 0.270 |
Why?
|
| Hypoglycemic Agents | 1 | 2010 | 475 | 0.240 |
Why?
|
| Glomus Tumor | 1 | 2024 | 14 | 0.220 |
Why?
|
| Synaptophysin | 1 | 2024 | 18 | 0.220 |
Why?
|
| Carcinoid Tumor | 1 | 2024 | 24 | 0.220 |
Why?
|
| Neoplasms, Cystic, Mucinous, and Serous | 1 | 2023 | 8 | 0.200 |
Why?
|
| Pancreatic Cyst | 1 | 2023 | 28 | 0.190 |
Why?
|
| Fontan Procedure | 2 | 2015 | 189 | 0.180 |
Why?
|
| Liver | 4 | 2017 | 1799 | 0.170 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2010 | 1413 | 0.150 |
Why?
|
| Fatty Liver | 2 | 2016 | 220 | 0.130 |
Why?
|
| Hepatitis | 1 | 2017 | 57 | 0.130 |
Why?
|
| Pancreatic Neoplasms | 1 | 2023 | 732 | 0.120 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2016 | 75 | 0.120 |
Why?
|
| Risk Adjustment | 1 | 2015 | 57 | 0.110 |
Why?
|
| Lung Neoplasms | 1 | 2024 | 1542 | 0.110 |
Why?
|
| Adiponectin | 1 | 2015 | 124 | 0.110 |
Why?
|
| Cystic Fibrosis | 1 | 2017 | 267 | 0.110 |
Why?
|
| Colitis, Ulcerative | 1 | 2016 | 216 | 0.110 |
Why?
|
| Biopsy, Fine-Needle | 2 | 2024 | 107 | 0.100 |
Why?
|
| Heart Defects, Congenital | 2 | 2015 | 1894 | 0.090 |
Why?
|
| Young Adult | 8 | 2018 | 10104 | 0.090 |
Why?
|
| Biopsy | 4 | 2017 | 1252 | 0.090 |
Why?
|
| Hepatitis C, Chronic | 1 | 2015 | 367 | 0.080 |
Why?
|
| Adolescent | 10 | 2018 | 20982 | 0.080 |
Why?
|
| Pakistan | 1 | 2010 | 92 | 0.080 |
Why?
|
| Predictive Value of Tests | 4 | 2018 | 2297 | 0.080 |
Why?
|
| Hemodynamics | 1 | 2014 | 816 | 0.080 |
Why?
|
| Child, Preschool | 8 | 2018 | 15057 | 0.080 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 3101 | 0.070 |
Why?
|
| Body Mass Index | 1 | 2015 | 1695 | 0.070 |
Why?
|
| Hepatitis C | 1 | 2012 | 390 | 0.070 |
Why?
|
| Child | 10 | 2018 | 26299 | 0.070 |
Why?
|
| Biomarkers | 2 | 2017 | 3405 | 0.070 |
Why?
|
| Infant | 6 | 2018 | 13306 | 0.060 |
Why?
|
| Male | 11 | 2018 | 65266 | 0.060 |
Why?
|
| ROC Curve | 2 | 2018 | 615 | 0.060 |
Why?
|
| Female | 11 | 2018 | 71185 | 0.060 |
Why?
|
| Adult | 6 | 2018 | 31719 | 0.050 |
Why?
|
| Humans | 13 | 2024 | 131679 | 0.050 |
Why?
|
| Cyst Fluid | 1 | 2023 | 6 | 0.050 |
Why?
|
| Cross-Sectional Studies | 3 | 2017 | 3834 | 0.050 |
Why?
|
| Mucins | 1 | 2023 | 69 | 0.050 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2000 | 67 | 0.040 |
Why?
|
| Dinoprostone | 1 | 2000 | 67 | 0.040 |
Why?
|
| Nitric Oxide Synthase | 1 | 2000 | 168 | 0.040 |
Why?
|
| Isoenzymes | 1 | 2000 | 216 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2024 | 1911 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2000 | 303 | 0.030 |
Why?
|
| Middle Aged | 3 | 2015 | 28888 | 0.030 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2016 | 49 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2000 | 466 | 0.030 |
Why?
|
| Alanine Transaminase | 1 | 2017 | 156 | 0.030 |
Why?
|
| Prevalence | 2 | 2015 | 2694 | 0.030 |
Why?
|
| Biomarkers, Tumor | 1 | 2024 | 1617 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2018 | 5123 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2000 | 667 | 0.030 |
Why?
|
| Massachusetts | 1 | 2015 | 118 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2018 | 8589 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2017 | 17667 | 0.030 |
Why?
|
| Chitinase-3-Like Protein 1 | 1 | 2013 | 3 | 0.030 |
Why?
|
| Lectins | 1 | 2013 | 50 | 0.020 |
Why?
|
| Boston | 1 | 2013 | 117 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2014 | 192 | 0.020 |
Why?
|
| Adipokines | 1 | 2013 | 121 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2013 | 320 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2014 | 6494 | 0.020 |
Why?
|
| Infectious Disease Medicine | 1 | 2012 | 13 | 0.020 |
Why?
|
| Hepatitis C Antibodies | 1 | 2012 | 26 | 0.020 |
Why?
|
| Florida | 1 | 2012 | 72 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 1517 | 0.020 |
Why?
|
| Hyaluronic Acid | 1 | 2013 | 108 | 0.020 |
Why?
|
| Linear Models | 1 | 2014 | 695 | 0.020 |
Why?
|
| Fibrosis | 1 | 2013 | 414 | 0.020 |
Why?
|
| Aged | 1 | 2010 | 21260 | 0.020 |
Why?
|
| Health Surveys | 1 | 2012 | 263 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 2143 | 0.020 |
Why?
|
| Nutrition Surveys | 1 | 2012 | 327 | 0.020 |
Why?
|
| Hepacivirus | 1 | 2012 | 273 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 1405 | 0.020 |
Why?
|
| Disease Progression | 1 | 2016 | 2206 | 0.020 |
Why?
|
| Public Health | 1 | 2012 | 277 | 0.020 |
Why?
|
| Risk Factors | 2 | 2015 | 10959 | 0.020 |
Why?
|
| Cardiac Catheterization | 1 | 2014 | 635 | 0.020 |
Why?
|
| Hospitals, Pediatric | 1 | 2013 | 794 | 0.020 |
Why?
|
| Age Factors | 1 | 2015 | 2872 | 0.020 |
Why?
|
| Liver Transplantation | 1 | 2016 | 1131 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 5297 | 0.020 |
Why?
|
| Phenotype | 1 | 2016 | 4516 | 0.020 |
Why?
|
| Time Factors | 1 | 2014 | 6279 | 0.010 |
Why?
|
| Pediatrics | 1 | 2012 | 1231 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2000 | 91 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2000 | 128 | 0.010 |
Why?
|
| Tacrolimus | 1 | 2000 | 104 | 0.010 |
Why?
|
| Cyclosporine | 1 | 2000 | 129 | 0.010 |
Why?
|
| Hydrocortisone | 1 | 2000 | 224 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2000 | 302 | 0.010 |
Why?
|
| Sirolimus | 1 | 2000 | 231 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2014 | 12984 | 0.010 |
Why?
|
| United States | 1 | 2012 | 11804 | 0.010 |
Why?
|
| Macrophages | 1 | 2000 | 666 | 0.010 |
Why?
|
| Gene Expression | 1 | 2000 | 1502 | 0.010 |
Why?
|
| Cell Line | 1 | 2000 | 2605 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2000 | 2568 | 0.010 |
Why?
|
| Mice | 1 | 2000 | 18488 | 0.000 |
Why?
|
| Animals | 1 | 2000 | 34375 | 0.000 |
Why?
|